Search results
What good are whizzy new drugs if the world can’t afford them?
The Economist· 2 hours agoIN RECENT YEARS biotechnology and pharmaceutical science have produced quantum leaps that both offer great opportunity and pose great risk. Gene therapies for rare conditions ...
Anti-obesity drugs will be 2024’s defining trend
Clinical Trials Arena via Yahoo Finance· 2 days agoGlobalData’s latest update notes the impact of the growing anti-obesity market, personalised medicines, real-world evidence, and cell and gene therapies.
Weight Loss Drugs Like Wegovy and Ozempic May Change Sense of Taste
Prevention via Yahoo News· 24 hours agoWeight loss drugs like Wegovy and Ozempic may change sense of taste and how the brain reacts to...
Ozempic and Wegovy Might Change How You Taste Different Flavors
Verywell Health via Yahoo News· 21 hours agoThe study included 30 women with obesity. Over 16 weeks, participants were randomized to receive a...
Avidity drug for muscular dystrophy shows promise; Syntis takes new approach to weight loss
BioPharma Dive via Yahoo Finance· 2 days agoStudy results indicated Avidity’s medicine muted target genes. Elsewhere, Syntis revealed obesity...
Ozempic, Wegovy, Mounjaro popularity soar as weight loss wonders
Pittsburgh Tribune-Review· 1 day agoFor Diane Lang, the big push to focus on her health and weight came from her grandchildren. Lang, of...
Opinion | Why Oprah’s medical weight loss message is still so muddled
MSNBC· 5 days agoNow, thanks to a new class of drugs that includes Ozempic, Wegovy and Mounjaro, Oprah’s struggles...
Research seeks to demystify obesity's link to type 2 diabetes
Medical Xpress· 3 days agoThe study is published in the journal Diabetes. Dr. Hanieh Yaghootkar, Senior Lecturer in Precision...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 3 days agoPatients taking certain medications or with two copies of a gene called APOE4 are more likely to...
The 'Impressive' Results That Sent This Top 1% Player To A Record
Investor's Business Daily· 2 days agoThe company is working on a treatment called del-brax for patients with facioscapulohumeral muscular...